Ultragenyx Pharmaceutical | RARE - Trade Creditors

Stock Price
24.45
Daily Change
-0.24 -0.97%
Monthly
8.47%
Yearly
-46.59%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $40.57M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Acadia Pharmaceuticals USD 21.75M 1.65M Sep/2025
Agios Pharmaceuticals USD 19.55M 2.02M Sep/2025
Alnylam Pharmaceuticals USD 117.59M 15.2M Sep/2025
BioMarin Pharmaceutical USD 798.44M 114.19M Sep/2025
Insmed USD 79.59M 1.24M Sep/2025
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Kyowa Hakko Kirin JPY 123.72B 14.99B Sep/2025
MacroGenics USD 5.94M 1.28M Sep/2025
Moderna USD 267M 92M Sep/2025
Neurocrine Biosciences USD 119.9M 15.3M Sep/2025
PTC Therapeutics USD 36.62M 169.69M Sep/2025
Regeneron Pharmaceuticals USD 5.83B 4.93B Dec/2025
Sarepta Therapeutics USD 94.02M 42.69M Sep/2025
Ultragenyx Pharmaceutical USD 40.57M 6.33M Sep/2025
Vertex Pharmaceuticals USD 4.03B 320.8M Sep/2025